Tom Brady with Lua. Photograph: Individuals
Tom Brady has revealed that his household’s new canine, Junie, is definitely a clone of his late pet Lua, created utilizing cutting-edge cloning know-how from Colossal Biosciences, a Dallas-based biotech agency wherein the retired NFL legend is an investor.
In keeping with Individuals, Brady collaborated with Colossal to clone Lua, a pit bull combine he shared along with his ex-wife, Gisele Bundchen, and their kids. Lua died in December 2023, however earlier than her demise, a blood pattern was collected to protect her genetic materials.
Utilizing that pattern, scientists efficiently produced Junie, whom Brady describes as a “second likelihood” for his household. “I like my animals. They imply the world to me and my household,” Brady mentioned in an announcement.
“A number of years in the past, I labored with Colossal and leveraged their non-invasive cloning know-how via a easy blood draw of our household’s aged canine earlier than she handed. That gave my household a second likelihood with a clone of our beloved Lua.”
Colossal lately acquired Viagen, the identical firm identified for cloning Barbra Streisand’s canine, Samantha, and Paris Hilton’s lacking pet, Diamond Child. Viagen’s cloning course of is predicated on know-how developed by the Roslin Institute in Edinburgh, which famously cloned Dolly the Sheep within the Nineteen Nineties.
Past pet cloning, Colossal has made headlines for its daring scientific targets, together with efforts to revive extinct species such because the woolly mammoth and the dodo chicken. Brady mentioned he hopes Colossal’s partnership with Viagen Pets and Equine will carry consolation to grieving pet house owners whereas additionally advancing the preservation of endangered animals.
